Showing 101 - 120 results of 167 for search '"Esophageal cancer"', query time: 0.46s Refine Results
  1. 101

    Impact of enhanced chest CT with three-dimensional reconstruction combined with preoperative olive oil administration on the incidence of postoperative chylothorax: a retrospective... by Xindong Luo, Di Lu, Ziqiang Wang, Jingyi Wang, Ruozhu Dong, Yaping Wang, Wei Cao, Dacheng Jin, Zhaohao Lin, Haochi Li, Pengcheng Du, Yunjiu Gou, Pengcheng Dong, Yayuan Yang

    Published 2025-02-01
    “…Abstract Background Chylothorax is a rare but potentially life-threatening complication after esophageal cancer resection. This study aims to investigate the impact of a strategy combining preoperative three-dimensional (3D) reconstruction of contrast-enhanced chest CT with olive oil ingestion on the incidence of chylothorax following esophageal cancer resection. …”
    Get full text
    Article
  2. 102

    The first case of esophageal mediastinal fistula after immunotherapy for non-small cell lung cancer: case report and literature review by Tianxiao Fu, Jiu Chen, Bing Xiong, Guolin Wu

    Published 2025-01-01
    “…Abstract Background Malignant esophageal mediastinal fistula is a severe complication that occurs in both the advanced stages of esophageal cancer and after radiotherapy for esophageal cancer. …”
    Get full text
    Article
  3. 103

    SKF96365 Inhibits Tumor Proliferation by Inducing Apoptosis and Autophagy in Human Esophageal Squamous Cell Carcinoma by Jiaxin Zhang, Huiqiong Han, Yihan Liu, Jiayao Xu, Daidi Zhang, Wenjia Wang, Yaping Gao, Zhengrui Li, Yanru Qin

    Published 2024-01-01
    “…In summary, SKF96365 induces apoptosis (PARP, caspase-9, and BCL-2) and autophagy (LC3-A/B) by inhibiting TRPC1 in esophageal cancer cells, thereby inhibiting tumor growth.…”
    Get full text
    Article
  4. 104

    Advancing precision medicine in esophageal squamous cell carcinoma using patient-derived organoids by Suya Shen, Bing Liu, Wenyan Guan, Ziyao Liu, Yuqing Han, Yingzhe Hu, Yiqiang Chen, Siyuan Liu, Jian He, Zhiwen Li, Weifeng Tang, Pengju Zhang, Wei Ren, Yudong Qiu, Hongping Zheng, Jingjing Li

    Published 2024-12-01
    “…Methods Fresh surgical biopsies were obtained from patients with esophageal cancer for the establishment of PDOs. These PDOs were subsequently characterized through histological analysis. …”
    Get full text
    Article
  5. 105

    Results of Photodynamic Therapy in Barrett’s Esophagus: A Review by Bergein F Overholt

    Published 1999-01-01
    “…Barrett’s esophagus is associated with an increased occurrence of mucosal dysplasia and adenocarcinoma in the specialized glandular mucosa, with a 30- to 52-fold increase in the occurrence of esophageal cancer compared with the normal population. …”
    Get full text
    Article
  6. 106

    Resection of the Gastric Tube Reconstructed through the Retrosternal Route without Sternotomy by Masahiro Kimura, Yasuyuki Shibata, Kotaro Mizuno, Hironori Tanaka, Motoki Hato, Satoshi Taniwaki, Yoichiro Mori, Nobuo Ochi, Takaya Nagasaki, Shuhei Ueno, Yuki Eguchi

    Published 2017-01-01
    “…With advances of combined modality therapy, prognoses in esophageal cancer have been improving. After resection of esophageal cancer, the development of gastric tube cancer is a risk. …”
    Get full text
    Article
  7. 107

    3-Epi-betulinic acid 3-O-β-D-glucopyranoside (eBAG) induces autophagy by activation of AMP-activated protein kinase in hepatocellular carcinoma by Mengjie Liu, Xuqiang Liu, Kaiyue He, Yongping Jian, Yujia Li, Jinrong Guo, Jingyu Yang, Zhixiang Xu, Wenyi Kang

    Published 2024-05-01
    “…As a functional food ingredient, eBAG is a potential therapeutic agent for the treatment of hepatocellular carcinoma and esophageal cancer.…”
    Get full text
    Article
  8. 108

    Barrett’s Esophagus: Is It All That Bad? by GNJ Tytgat

    Published 1999-01-01
    “…Given the low five-year survival rate in patients with advanced esophageal cancer, strategies for early detection have been developed. …”
    Get full text
    Article
  9. 109
  10. 110

    Spatiotemporal Correlation Analysis for the Incidence of Esophageal and Gastric Cancer From 2010 to 2019: Ecological Study by Zixuan Cui, Chen Suo, Yidan Zhao, Shuo Wang, Ming Zhao, Ruilin Chen, Linyao Lu, Tiejun Zhang, Xingdong Chen

    Published 2025-01-01
    “…Malawi was identified as the highest risk for esophageal cancer (male RR=3.27; female RR=5.19) and low risk for gastric cancer (male RR=0.21; female RR=0.23) in both sexes. …”
    Get full text
    Article
  11. 111

    Obesity Is Associated with Early Onset of Gastrointestinal Cancers in California by Yen-Yi Juo, Melinda A. Maggard Gibbons, Erik Dutson, Anne Y. Lin, Jane Yanagawa, O. Joe Hines, Guido Eibl, Yijun Chen

    Published 2018-01-01
    “…The diagnosis of obesity (BMI > 30) was associated with a reduction in diagnosis age across all four cancer types: 3.25 ± 0.53 years for gastric cancer, 4.56 ± 0.18 years for colorectal cancer, 4.73 ± 0.73 years for esophageal cancer, and 5.35 ± 0.72 for pancreatic cancer. …”
    Get full text
    Article
  12. 112

    Tobacco smoking-attributable mortality in Kenya, 2012–2021 by Lazarus Odeny, Gladwell Gathecha, Valerian Mwenda, Anne Kendagor, Samuel Cheburet, Beatrice Mugi, Caroline Mithi, Florence Jaguga, Kennedy Okinda, Rachel K. Devotsu, Shukri F. Mohamed, Jane Rahedi Ong’ang’o

    Published 2024-07-01
    “…Pneumonia and influenza, esophageal cancer, chronic airway obstruction, and tuberculosis were primary causes, comprising 70% of all SAM. …”
    Get full text
    Article
  13. 113

    Efficacy and safety of nivolumab plus ipilimumab in gastrointestinal cancers: a systematic review and meta-analysis by Bowen Dai, Jiaping Jiang, Xiaoyu Yu, Haihua Zhan, Zhengchuan Hu

    Published 2025-01-01
    “…Subgroup analysis demonstrated that the ORR (OR = 1.75, P = 0.02) and mOS (MD = 5.02, P = 0.003) were significantly improved in patients with esophageal cancer. Notably, the ORR in patients with biliary cancer was significantly lower (OR = 0.11, P = 0.04). …”
    Get full text
    Article
  14. 114

    What is true and what is new in esophageal microbiome in 2024? by M. Jauvain, E. Bessède

    Published 2024-10-01
    “…This review will outline data from studies published in the past year, mainly focusing on esophageal cancer and motility disorders, characterizing the esophageal microbiome in both health and disease states.…”
    Get full text
    Article
  15. 115

    Outcome of Pleural Empyema Treated With Video-Assisted Thoracoscopic Surgery in Patients With Severe Co-Morbidities: An Observational Study by Vu HA, Nguyen NV, Le TD, Nguyen ST, Viet Le A, The Vu A, Van Nguyen B, Van Nguyen B, Thanh Quan N, An NV, Duc Nghiem T

    Published 2025-01-01
    “…Some comorbidities contained chronic obstructive pulmonary disease (COPD) (25.0%), spontaneous esophageal perforation (16.7%), liver cancer, cirrhosis, esophageal cancer, end-stage renal failure – chronic dialysis (8.7%). …”
    Get full text
    Article
  16. 116
  17. 117

    Endoscopic Mucosal Resection for Esophageal and Gastric Mucosal Cancers by Haruhiro Inoue

    Published 1998-01-01
    “…The author used endoscopic mucosal resection (EMR) as curative treatment in 142 cases of esophageal cancer and 102 cases of stomach cancer. In absolutely indicated cases there has been no local or distant metastasis during the longest period of follow-up (nine years). …”
    Get full text
    Article
  18. 118

    An esophageal stent integrated with wireless battery-free movable photodynamic-therapy unit for targeted tumor treatment by Qian Han, Pingjin Zou, Xianhao Wei, Junyang Chen, Xiaojiao Li, Li Quan, Ranlin Wang, Lili Xing, Xinyu Xue, Yi Zhou, Meihua Chen

    Published 2025-02-01
    “…Esophageal cancer is the eighth most common cancer worldwide and the sixth leading cause of cancer-related deaths. …”
    Get full text
    Article
  19. 119

    Management of Carcinoma of Esophagus in Old Patient with Panchagavya Therapy as a Palliative Care-A Case Report by Punam G. Sawarkar, Damini Raut, Nandini Bhojarj, Gaurav Sawarkar

    Published 2024-12-01
    “…Esophageal cancer is a male-dominant, aggressive malignancy with a five-year survival rate of 15%-20%, predominantly affecting developed nations. …”
    Get full text
    Article
  20. 120